Cause of the Most Devastating Pandemics in History Revealed
|
By LabMedica International staff writers Posted on 04 Feb 2014 |

Image: Tooth of one of the plague victims buried in Bavaria (Photo courtesy of McMaster University).
A new study reveals that two of the world's most devastating pandemics, the plague of Justinian and the Black Death, were caused by distinct strains of the same pathogen.
Researchers at McMaster University (Hamilton, ON, Canada), Northern Arizona University (Flagstaff, USA), the University of Sydney (Australia), and other institutions isolated miniscule DNA fragments from the 1,500 year old teeth of two victims of the Justinian plague, who were buried in the Aschheim-Bajuwarenring cemetery (Bavaria, Germany); these are the oldest pathogen genomes obtained to date. Using these short fragments, the researchers reconstructed the genome of the bacterium responsible, and compared it to a database of genomes of more than a hundred contemporary strains.
The results showed that the bacterium was a strain of Yersinia pestis, the same pathogen responsible for the Black Death. But while the strain responsible for the Justinian outbreak was an evolutionary “dead-end” and faded out on its own, the other, likely a descendant of the Black Death strain, lead to another worldwide pandemic spreading from Hong Kong across the globe in the late 1800’s. According to the researchers, these findings suggest a new strain of plague could emerge again in humans in the future. The study was published online on January 28, 2014, in the Lancet Infectious Diseases.
“About 200 rodent species carry the plague and could potentially infect other animals or humans. Scientists need to sharpen their surveillance of plague in rodent populations to try averting future human infections,” said lead author Associate Professor Hendrik Poinar, PhD, director of the McMaster Ancient DNA Center. “If we happen to see a massive die-off of rodents somewhere, then it would become alarming. Plague is something that will continue to happen, but modern-day antibiotics should be able to stop it.”
The Plague of Justinian struck in the sixth century and it is estimated to have killed between 30 and 50 million people—virtually half the world's population—as it spread across Asia, North Africa, The Arabian peninsula, and Europe. The Black Death struck some 800 years later with similar force, killing 50 million Europeans in just four years (1347-1351).
Related Links:
McMaster University
Northern Arizona University
University of Sydney
Researchers at McMaster University (Hamilton, ON, Canada), Northern Arizona University (Flagstaff, USA), the University of Sydney (Australia), and other institutions isolated miniscule DNA fragments from the 1,500 year old teeth of two victims of the Justinian plague, who were buried in the Aschheim-Bajuwarenring cemetery (Bavaria, Germany); these are the oldest pathogen genomes obtained to date. Using these short fragments, the researchers reconstructed the genome of the bacterium responsible, and compared it to a database of genomes of more than a hundred contemporary strains.
The results showed that the bacterium was a strain of Yersinia pestis, the same pathogen responsible for the Black Death. But while the strain responsible for the Justinian outbreak was an evolutionary “dead-end” and faded out on its own, the other, likely a descendant of the Black Death strain, lead to another worldwide pandemic spreading from Hong Kong across the globe in the late 1800’s. According to the researchers, these findings suggest a new strain of plague could emerge again in humans in the future. The study was published online on January 28, 2014, in the Lancet Infectious Diseases.
“About 200 rodent species carry the plague and could potentially infect other animals or humans. Scientists need to sharpen their surveillance of plague in rodent populations to try averting future human infections,” said lead author Associate Professor Hendrik Poinar, PhD, director of the McMaster Ancient DNA Center. “If we happen to see a massive die-off of rodents somewhere, then it would become alarming. Plague is something that will continue to happen, but modern-day antibiotics should be able to stop it.”
The Plague of Justinian struck in the sixth century and it is estimated to have killed between 30 and 50 million people—virtually half the world's population—as it spread across Asia, North Africa, The Arabian peninsula, and Europe. The Black Death struck some 800 years later with similar force, killing 50 million Europeans in just four years (1347-1351).
Related Links:
McMaster University
Northern Arizona University
University of Sydney
Latest Microbiology News
- Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
- Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
- Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
- Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
- 15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
New Blood Biomarkers Help Diagnose Pregnancy-Linked Liver Complication
Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disorder linked to pregnancy and can pose serious risks for both mother and baby, including premature delivery and stillbirth.... Read more
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read moreHematology
view channel
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups
Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Tumor Signals in Saliva and Blood Enable Non-Invasive Monitoring of Head and Neck Cancer
Head and neck cancers are among the most aggressive malignancies worldwide, with nearly 900,000 new cases diagnosed each year. Monitoring these cancers for recurrence or relapse typically relies on tissue... Read more
Common Health Issues Can Influence New Blood Tests for Alzheimer’s Disease
Blood-based tests for Alzheimer’s disease are transforming diagnosis by offering a simpler alternative to spinal taps and brain imaging. However, many people evaluated at memory clinics also live with... Read more
Blood Test Formula Identifies Chronic Liver Disease Patients with Higher Cancer Risk
Chronic liver disease affects millions worldwide and can progress silently to hepatocellular carcinoma (HCC), one of the deadliest cancers globally. While surveillance guidelines exist for patients with... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more







 assay.jpg)
